Skip to content

breast cancer chemotherapy risk prediction mathematical model

macro-microscopic syndrome differentiation combination,based on the chinese medicine clinical phenotype to construct breast cancer chemotherapy risk prediction mathematical model

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-15007026
Enrollment
Unknown
Registered
2015-03-31
Start date
2015-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast neoplasms

Interventions

Case series:Nil

Sponsors

The First Affiliated Hospital of Xi'an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: the female patients diagnosed with breast cancer by first histopathology; no tumor intervention therapy was conducted within one prior to the survey; kps score>=60; patients without sever idiopathic disease; patients who can independently respond to a questionnaire; those who signed informed consent.

Exclusion criteria

Exclusion criteria: patients with sever idiopathic disease of the gastrointestinal tract, heart blood vessels, liver, kidney, hematopoietic tem, endocrine tem so on; patients with previous or ongoing application of drugs affecting bone marrow hemoatopoietic function; patients who complicated with a serious infection or severe liquid sickness; psychiatric patients; those who can not independently respond to a questionnaire.

Design outcomes

Primary

MeasureTime frame
Myelosuppression of chemotherapy;

Countries

China

Contacts

Public Contactliu yi
liuyi.jiaotong@163.com+86 18991232576

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026